Current role
Biotechnology · Healthcare
General Counsel, COO
2025-04-18–present
R. Christopher Cook
Equibles does not estimate personal net worth.
Get an email with a short summary when Filana Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FLNA alertsAbout R. Christopher Cook
R. Christopher Cook is recorded as COO at Filana Therapeutics, Inc. (FLNA) since April 18, 2025 and General Counsel at Filana Therapeutics, Inc. (FLNA). The newest filing on record that lists R. Christopher Cook as General Counsel at Filana Therapeutics, Inc. (FLNA) is dated April 14, 2025. Filana Therapeutics, Inc. reported in an 8-K filed April 21, 2025 that R. Christopher Cook was appointed Chief Operating and Legal Officer, effective April 18, 2025. Filana Therapeutics, Inc. reported in an 8-K filed October 27, 2022 that R. Christopher Cook was appointed Senior Vice President and General Counsel, effective December 1, 2022. The proxy statement of Filana Therapeutics, Inc. reports total compensation of $818,985 for R. Christopher Cook in fiscal 2025, including a base salary of $463,975. Disclosed compensation is on record for 4 fiscal years. Filana Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Filana Therapeutics, Inc. includes Richard (Rick) Barry (CEO), Richard J. Barry (CEO, Chairman and Board Member), Claude Nicaise (Chairman) and 7 others.
“On April 18, 2025, Mr. Cook, previously our Senior Vice President and General Counsel, was appointed Chief Operating and Legal Officer of the Company.”
“On October 27, 2022, Cassava Sciences, Inc. (the “Company”) announced the appointment of R. Christopher Cook, age 58, as Senior Vice President and General Counsel, effective on or before December 1, 2022.”
Affiliation history
-
Current
2025-04-18–present
-
Current
Start not stated–present
Last confirmed April 14, 2025
-
Filana Therapeutics, Inc. (FLNA)
Proxy statement
CurrentStart not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Filana Therapeutics, Inc.
- Richard (Rick) Barry CEO
- Richard J. Barry CEO, Chairman, Board Member
- Claude Nicaise Chairman
- Claude Nicaise, M.D. Chairman, Board Member
- Eric J. Schoen CFO
- Dawn C. Bir Board Member
- Dawn Carter Bir Board Member
- Dr. Claude Nicaise Board Member
- Jill M. Quigley Board Member
- Michael J. O'Donnell Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Filana Therapeutics, Inc. (FLNA) | Chief Operating and Legal Officer | $463,975 | $818,985 |
| 2024 | Filana Therapeutics, Inc. (FLNA) | Chief Operating and Legal Officer | $438,000 | $3,295,128 |
| 2023 | Filana Therapeutics, Inc. (FLNA) | Sr. VP and General Counsel | $425,000 | $1,269,275 |
| 2022 | Filana Therapeutics, Inc. (FLNA) | Sr. VP and General Counsel | $74,102 | $3,656,062 |